Manufacturing Deviation Case Studies – Page 3

Deviation closed without effectiveness check during changeover – root cause analysis failure explained

On an ordinary production day, the quality control team observed variations in tablet weight during a scheduled changeover from one product to another. The initial symptoms included:Click to read the…

Critical IPC skipped during changeover – regulatory impact assessment case study

The first clue that an IPC had been skipped came during routine batch record review prior to the release of a new product. Operators noted that the scheduled **pH checks**…

Unapproved process parameter change during tech transfer – CAPA ineffectiveness identified

During the tech transfer of a solid oral dosage form, operators noticed deviations in product consistency and dissolution profile results, which raised immediate red flags. Quality Control (QC) analysts reported…

Critical IPC skipped during routine manufacturing – CAPA ineffectiveness identified

The incident first came to light during a routine internal audit when discrepancies in batch records were identified. Operators reported anomalies, such as variations in product uniformity and discrepancies in…

Critical IPC skipped during routine manufacturing – CAPA ineffectiveness identified

In the described case, operators noticed discrepancies in the weight of the product batches during the final fill stages. The following signals prompted immediate concerns:Click to read the full article.

Batch executed with expired SOP during commercial campaign – regulatory impact assessment case study

Upon review of batch records following the production of a commercial drug product, discrepancies were noted during the quality control (QC) checks. The initial symptoms included:Click to read the full…

Batch executed with expired SOP during commercial campaign – regulatory impact assessment case study

Case Study: Regulatory Impact Assessment of a Batch Executed with an Expired SOP in a Commercial Campaign In an environment where precision is paramount, the execution of a batch under…

Equipment used without release during routine manufacturing – regulatory impact assessment case study

In the context of pharmaceutical manufacturing, the first indication of a potential deviation is often found in unexpected product quality results. In this scenario, an abnormal trend in batch release…

Equipment used without release during routine manufacturing – regulatory impact assessment case study

During routine quality checks at the manufacturing facility, multiple alarms were triggered due to electronic issues associated with the equipment. The following symptoms were observed:Click to read the full article.

Unplanned hold time extension during inspection preparation – root cause analysis failure explained

Upon deployment for a scheduled FDA inspection, the quality control (QC) team noted several symptoms indicating a hold time extension. Key signals included excessive delays in processing batches and discrepancies…

Unplanned hold time extension during inspection preparation – root cause analysis failure explained

During an internal audit conducted in preparation for an upcoming FDA inspection, operators reported an unplanned extension of hold times for critical materials. Initial signals included:Click to read the full…

Unapproved process parameter change during inspection preparation – CAPA ineffectiveness identified

The issue began to emerge during routine checks ahead of an FDA inspection. Operators noticed discrepancies in batch records related to the mixing temperature for a critical intermediate in the…